vendredi 28 avril 2017

Onco Actu du 28 avril 2017

1. Biologie

Cell Lines Gain Cancer-Related Mutations [The Scientist]

5. Traitements

Cancer treatment hype gives false hope to many patients [USA Today]

5.2 Pharma

Pfizer’s Next-Generation ALK/ROS1 Inhibitor, Lorlatinib, Granted Breakthrough Therapy Designation from FDA for ALK-Positive Metastatic Non-Small Cell Lung Cancer [Pfizer]

Pfizer wins a “breakthrough” title for ALK/ROS1 contender lorlatinib after hustling into PhIII [EndPoints]

5.2.3 Pharma - économie

Thought Opdivo was down and out? Think again, Bristol-Myers says with first-quarter beats [FiercePharma]

A Refreshing Voice At Bristol-Myers Squibb [Forbes]

5.3 Traitements - FDA, EMA, NICE...

Gottlieb’s FDA Nomination Gets Committee Nod, Advances to Senate [Xconomy]

Senate committee votes to advance Gottlieb’s nomination to lead FDA [STAT]

Senate committee backs Scott Gottlieb as next FDA commissioner [EndPoints]

5.3.4 Traitements - AMM (FDA, EMA)

Bayer Receives FDA Approval for Stivarga® (regorafenib) for the Second-Line Systemic Treatment of Liver Cancer [Bayer]

FDA expands approved use of Stivarga to treat liver cancer [FDA]

Bayer's Stivarga Shows Slim Progress Against Liver Cancer [Forbes]

FDA approves Bayer's Stivarga to treat most common liver cancer [Reuters]

5.4 Traitements - Economie

£1.27 billion Cancer Drugs Fund a political 'quick-fix' that harmed some patients, review finds [The Telegraph]

Cancer Drugs Fund 'huge waste of money' [BBC News]

Cancer Drugs Fund condemned as expensive and ineffective [The Guardian]

UK cancer fund was poor value and may have caused patient suffering [Reuters]

6.1 Observation

Thousands of cancer patients denied wish to die at home [The Guardian]

6.10.1 Politiques (USA)

Value-Based Pricing For Pharmaceuticals In The Trump Administration [Health Affairs Blog]

6.11 Patients

Patients Who Choose No Intervention for Small Thyroid Cancers Report Lack of Support [NCI]

6.5 Médecines alternatives

The FDA cracks down on bogus cancer “cures.” Will this be the last time this happens until after Trump? [Respectful Insolence]

6.6 Publications

Phony peer review: The more we look, the more we find [STAT]

6.8 Communication

A before & after look at this weekend’s breast cancer conference: How will reporters cover it? (Part One) [HealthNewsReview]